Home

Latest News

Carcinoid/Neuroendocrine Tumor Presentations at ASCO Annual Meeting

Twenty-six abstracts about carcinoid and other NETs will be presented at the 2013 ASCO (American Society of Clinical Oncology) Annual Meeting, to be held May 31 to June 4 in Chicago, Illinois. Cutting-edge scientific presentations and comprehensive educational content will be shared with more than 25,000 oncology professionals from a broad range of specialties, exploring the theme of the Meeting — "Building Bridges to Conquer Cancer." Click here for the carcinoid/NETs presentations.

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging Patient Program

Josh Mailman, President of the NorCal CarciNET support group and Chair of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day on June 9th in Vancouver, British Columbia, Canada. The “Patient Program” provides a unique opportunity to network with passionate advocates and leading experts in neuroendocrine tumors (NETs), lymphoma disease, and dementia. Read more

Mayo Clinic Completes First Whole Exome Sequence of Small Intestine Neuroendocrine Tumors

Researchers at the Mayo Clinic in Rochester, Minnesota have completed the first whole exome sequence of small intestine neuroendocrine tumors and have identified six pathways as potential drug targets for these NETs. Read more about the Mayo Clinic research here. Click here for the full text article. And learn more about exome sequencing.

Living Well with Carcinoid and Neuroendocrine Tumors

Work with a multidisciplinary team, educate yourself, seek out online support groups, find physicians who know how to treat you, focus on achieving the best quality of life possible -- these are some of the suggestions offered by carcinoid and neuroendocrine tumor specialists and patients.  "Living Well with Carcinoid and Neuroendocrine Tumors" provides insights into being diagnosed with rare diseases and physicians' guidance for their patients.

Surgery and Treatment Options for NET Cancers

What are the surgical and treatment options for carcinoid and neuroendocrine tumor patients?  For patients with tumors that have spread to the liver which therapies should be used to improve quality and quantity of life?  How do patients benefit from clinical trials?  There is an explosion of technologies coming not only in the diagnostics but also in the treatments of these rare cancers.  View the latest video from the Carcinoid Cancer Foundation:http://bit.ly/VcJXgz

Surgery and Treatment Options for Neuroendocrine Cancer Pations

Lung Carcinoid

According to the latest research, 28% of all carcinoids occur in the lung.  What are the symptoms of lung carcinoid?  Do these tumors cause carcinoid syndrome?  Learn more from carcinoid and neuroendocrine tumor experts about imaging and surgery for lung carcinoids.  Meet two lung carcinoid survivors, Kenneth and Kathy.  Kenneth has completed more than a dozen marathons since he had his lung removed.  Read an inspiring story about lung carcinoid survivors here.

Carcinoid Cancer Foundation Releases "Faces of Hope" Video on NET Cancer Day

In recognition of the 3rd Annual Worldwide NET Cancer Awareness Day on November 10, 2012, the Carcinoid Cancer Foundation released the video,"Faces of Hope." Meet NET cancer survivors Claire, Josh, Judy, Kathy, Kenneth, and "Sunny" Susan as they share their journeys about being diagnosed and living with rare neuroendocrine tumors, including lung carcinoid, carcinoid of the ileum, and pancreatic neuroendocrine tumors.  Future videos in the series will focus on surgery and treatment options, lung carcinoid, and nutrition. (Click on the YouTube logo below to see the video in a larger format.)